Initial results of a 12-week, institution-based, supervised exercise rehabilitation program for the management of peripheral arterial disease

Vascular

Volumn 18, Issue 6, 2010, Pages 325-335

  Franz, Randall W ^a   Garwick, Tammy ^a   Haldeman, Katie ^b  

^a GRANT MEDICAL CENTER   (United States)

^b RIVERSIDE METHODIST HOSPITAL   (United States)

Author keywords

Claudication; Exercise; Outcomes; Peripheral arterial disease; Rehabilitation; Supervised exercise

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; EXERCISE TOLERANCE; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; KINESIOTHERAPY; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; WALKING DIFFICULTY;

ADULT; AGED; AGED, 80 AND OVER; ANKLE BRACHIAL INDEX; BLOOD PRESSURE; BODY MASS INDEX; BODY WEIGHT; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; COMBINED MODALITY THERAPY; EXERCISE TEST; EXERCISE THERAPY; EXERCISE TOLERANCE; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; OHIO; PERIPHERAL ARTERIAL DISEASE; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RECOVERY OF FUNCTION; TIME FACTORS; TREATMENT OUTCOME; WALKING;

EID: 78649828834     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.2310/6670.2010.00053     Document Type: Article

References (57)

1. Aquino R, Johnnides C, Makaroun M, et al. Natural history of claudication: long-term serial follow-up study of 1244 claudicants. J Vasc Surg 2001;34:962-70. (Pubitemid 33660652)
2. Falcone RA, Hirsch AT, Regensteiner JG, et al. Peripheral arterial disease rehabilitation: a review. J Cardiopulm Rehabil 2003;23: 170-5.
3. Gardner AW, Afaq Z. Management of lower extremity peripheral arterial disease. J Cardiopulm Rehabil Prev 2008;28:349-57.
4. Mouser MJ, Zlabek JA, Ford CL, Mathiason MA. Community trial of home-based exercise therapy for intermittent claudication. Vasc Med 2009;14:103-7.
5. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007;33Suppl 1:S1-75.
6. Regensteiner JG. Exercise rehabilitation for the patient with intermittent claudication: a highly effective yet underutilized treatment. Curr Drug Targets Cardiovasc Haematol Disord 2004; 4:233-9.
7. Comerota AJ. The case for early detection and integrated intervention in patients with peripheral arterial disease and intermittent claudication. J Endovasc Ther 2003;10:601-13.
8. Davies A. The practical management of claudication. BMJ 2000; 321:911-2.
9. Regensteiner JG, Stewart KJ. Established and evolving medical therapies for claudication in patients with peripheral arterial disease. Nat Clin Pract Cardiovasc Med 2006;3:604-10.
10. Gartenmann Ch, Kirchberger I, Herzig M, et al. Effects of exercise training program on functional capacity and quality of life in patients with peripheral arterial occlusive disease. Evaluation of a pilot project. Vasa 2002;31:29-34. (Pubitemid 34208460)
11. Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT. Exercise training for claudication. N Engl J Med 2002;347:1941-51.
12. Treesak C, Kasemsup V, Treat-Jacobson D, et al. Cost-effectiveness of exercise training to improve claudication symptoms in patients with peripheral arterial disease. Vasc Med 2004;9:279-85.
13. Adams J, Ogola G, Stafford P, et al. High-intensity interval training for intermittent claudication in a vascular rehabilitation program. J Vasc Nurs 2006;24:46-9.
14. Bendermacher BL, Willigendael EM, Teijink JA, Prins MH. Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev 2006; (2):CD005263.
15. Bulmer AC, Coombes JS. Optimising exercise training in peripheral arterial disease. Sports Med 2004;34:983-1003. (Pubitemid 39665191)
16. Crowther RG, Spinks WL, Leicht AS, et al. Effects of a long-term exercise program on lower limb mobility, physiological responses, walking performance, and physical activity levels in patients with peripheral arterial disease. J Vasc Surg 2008;47:303-9.
17. Degischer S, Labs KH, Hochstrasser J, et al. Physical training for intermittent claudication: a comparison of structured rehabilitation versus home-based training. Vasc Med 2002;7:109-15.
18. Feinberg RL, Gregory RT, Wheeler JR. The ischemic window: a method for the objective quantitation of the training effect in exercise therapy for intermittent claudication. J Vasc Surg 1992;16: 244-50.
19. Gardner AW, Katzel LI, Sorkin JD, et al. Exercise rehabilitation improves functional outcomes and peripheral circulation in patients with intermittent claudication: a randomized controlled trial. J Am Geriatr Soc 2001;49:755-62.
20. Gardner AW, Katzel LI, Sorkin JD, Goldberg AP. Effects of long-term exercise rehabilitation on claudication distances in patients with peripheral arterial disease: a randomized controlled trial. J Cardiopulm Rehabil 2002;22:192-8.
21. Gardner AW, Killewich JA, Montgomery PS, Katzel LI. Response to exercise rehabilitation in smoking and nonsmoking patients with intermittent claudication. J Vasc Surg 2004;39:531-8.
22. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA 1995; 274:975-80.
23. Hiatt WR, Regensteiner JG, Hargarten ME, et al. Benefits of exercise conditioning for patients with peripheral arterial disease. Circulation 1990;81:602-9.
24. Hiatt WR, Wolfel EE, Meier RH, Regensteiner JG. Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response. Circulation 1994;90:1866-74.
25. Izquierdo-Porrera AM, Gardner AW, Powell CC, Katzel LI. Effects of exercise rehabilitation on cardiovascular risk factors in older patients with peripheral arterial occlusive disease. J Vasc Surg 2000; 31:670-7.
26. Keo H, Grob E, Guggisberg F, et al. Long-term effects of supervised exercise training on walking capacity and quality of life in patients with intermittent claudication. Vasa 2008;37:250-6.
27. Leng GC, Fowler B, Ernst E. Exercise for intermittent claudication. Cochrane Database Syst Rev 2000;(2):CD000990.
28. McDermott MM, Ades P, Guralnik JM. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA 2009;14:165-74.
29. Menard JR, Smith HE, Riebe D, et al. Long-term results of peripheral arterial disease rehabilitation. J Vasc Surg 2004;39:1186-92.
30. Milani RV, Lavie CJ. The role of exercise training in peripheral arterial disease. Vasc Med 2007;12:351-8.
31. Patterson RB, Pinto B, Marcus B, et al. Value of a supervised exercise program for the therapy of arterial claudication. J Vasc Surg 1997;25:312-9.
32. Regensteiner JG. Exercise in the treatment of claudication: assessment and treatment of functional impairment. Vasc Med 1997;2:238-42.
33. Regensteiner JG, Gardner A, Hiatt WR. Exercise testing and exercise rehabilitation for patients with peripheral arterial disease: status in 1997. Vasc Med 1997;2:147-55.
34. Regensteiner JG, Meyer TJ, Krupski WC, et al. Hospital vs home-based exercise rehabilitation for patients with peripheral arterial occlusive disease. Angiology 1997;48:291-300. (Pubitemid 27172999)
35. Regensteiner JG, Steiner JF, Hiatt WR. Exercise training improves functional status in patients with peripheral arterial disease. J Vasc Surg 1996;23:104-15.
36. Robeer GG, Brandsma JW, van den Heuvel SP, et al. Exercise therapy for intermittent claudication: a review of the quality of randomized clinical trials and evaluation of predictive factors. Eur J Vasc Endovasc Surg 1998;15:36-43.
37. Savage P, Ricci MA, Lynn M, et al. Effects of home versus supervised exercise for patients with intermittent claudication. J Cardiopulm Rehabil 2001;21:152-7.
38. Tsai JC, Chan P,Wang CH. The effects of exercise training on walking function and perception of health status in elderly patients with peripheral arterial occlusive disease. J Intern Med 2002;252:448-55.
39. Watson L, Ellis B, Leng GC. Exercise for intermittent claudication. Cochrane Database Syst Rev 2008;(4):CD000990.
40. Williams LR, Ekers MA, Collins PS, Lee JF. Vascular rehabilitation: benefits of a structured exercise/risk modification program. J Vasc Surg 1991;14:320-6.
41. Wind J, Koelemay MJ. Exercise therapy and the additional effect of supervision on exercise therapy in patients with intermittent claudication. Systematic review of randomized controlled trials. Eur J Vasc Endovasc Surg 2007;34:1-9.
42. National Cholesterol Education Program. ATP III guidelines at-aglance quick desk reference. Bethesda (MD): National Heart, Lung, and Blood Institute; 2001. NIH Pub. No.: 01-3305.
43. National Cholesterol Education Program. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final report. Bethesda (MD): National Heart, Lung, and Blood Institute; 2002. NIH Pub. No.: 02-5215.
44. Chong PFS, Garratt AM, Golledge J, et al. The Intermittent Claudication Questionnaire: a patient-assessed condition-specific health outcome measure. J Vasc Surg 2002;36:764-71.
45. McDermott MM, Liu K, Guralnik JM, et al. Measurement of walking endurance and walking velocity with questionnaire: validation of the walking impairment questionnaire in men and women with peripheral arterial disease. J Vasc Surg 1998;28: 1072-81.
46. Regensteiner JG, Steiner JF, Panzer RJ, Hiatt WR. Evaluation of walking impairment by questionnaire in patients with peripheral arterial disease. J Vasc Med Biol 1990;2:142-50.
47. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. Transatlantic Inter-Society Consensus (TACS). J Vasc Surg 2000;31:S1-296.
48. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286:1317-24.
49. Aronow WS, Nayak D, Woodworth S, Ahn C. Effect of simvastin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment. Am J Cardiol 2003;92:711-2.
50. Mohler ER 3rd, Hiatt WR, Creager MA. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation 2003;108:1481-6.
51. Mondillo S, Ballo P, Barbati R, et al. Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease. Am J Med 2003;114:359-64.
52. Chi YW, Lavie CJ, Milani RV, White CJ. Safety and efficacy of cilostazol in the management of intermittent claudication. Vasc Health Risk Manag 2008;4:1197-203.
53. Dawson DL, Cutler BS, Meissner MH, Strandness DE Jr. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. Circulation 1998;98:678-86.
54. Hobbs SD, Marshall T, Fegan C, et al. The effect of supervised exercise and cilostazol on coagulation and fibrinolysis in intermittent claudication: a randomized controlled trial. J Vasc Surg 2007;45:65-70.
55. Money SR, Herd JA, Isaacsohn JL, et al. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease. J Vasc Surg 1998;27: 267-75.
56. Robless P, Mikhailidis DP, Stansby GP. Cilostazol for peripheral arterial disease. Cochrane Database Syst Rev 2008;(1): CD003748.
57. Wullink M, Stoffers HE, Kuipers H. A primary care walking exercise program for patients with intermittent claudication. Med Sci Sports Exerc 2001;33:1629-34. (Pubitemid 32963861)